α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis

被引：25

作者：

Butkovich, Laura M. ^{[1
]}

Houser, Madelyn C. ^{[1
]}

Tansey, Malu G. ^{[1
]}

机构：

[1] Emory Univ, Sch Med, Dept Physiol, Tansey Lab, Atlanta, GA 30322 USA

来源：

FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷

关键词：

alpha-synuclein; locus coeruleus; Parkinson's disease; neuroinflammation; norepinephrine; immune cell; SLEEP BEHAVIOR DISORDER; DOPAMINE-BETA-HYDROXYLASE; NEUROGENIC ORTHOSTATIC HYPOTENSION; ADRENERGIC-RECEPTOR ACTIVATION; COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; BRAIN-STEM NUCLEI; LOCUS-COERULEUS; SUBSTANTIA-NIGRA;

D O I：

10.3389/fnins.2018.00626

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

alpha-synuclein (alpha-syn) pathology and loss of noradrenergic neurons in the locus coeruleus (LC) are among the most ubiquitous features of Parkinson's disease (PD). While noradrenergic dysfunction is associated with non-motor symptoms of PD, preclinical research suggests that the loss of LC norepinephrine (NE), and subsequently its immune modulatory and neuroprotective actions, may exacerbate or even accelerate disease progression. In this review, we discuss the mechanisms by which alpha-syn pathology and loss of central NE may directly impact brain health by interrupting neurotrophic factor signaling, exacerbating neuroinflammation, and altering regulation of innate and adaptive immune cells.

引用

页数：13

共 50 条

[21] The interrelationship between intestinal immune cells and enteric α-synuclein in the progression of Parkinson's disease
Cheng, Yuan-Kai
Chiang, Hao-Sen
NEUROLOGICAL SCIENCES, 2025,
[22] The AAV-a-Synuclein a-Synuclein Model of Parkinson's Disease: An Update
Bjorklund, Anders
Mattsson, Bengt
JOURNAL OF PARKINSONS DISEASE, 2024, 14 (06) : 1077 - 1094
[23] Neuropathology of α-synuclein in Parkinson's disease
Choong, Chi-Jing
Mochizuki, Hideki
NEUROPATHOLOGY, 2022, 42 (02) : 93 - 103
[24] Agrochemicals, α-Synuclein, and Parkinson's Disease
Silva, Blanca A.
Breydo, Leonid
Fink, Anthony L.
Uversky, Vladimir N.
MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 598 - 612
[25] The role of the endolysosomal pathway in a-synuclein pathogenesis in Parkinson's disease
Smith, Jessica K.
Mellick, George D.
Sykes, Alex M.
FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 16
[26] Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice
Karikari, Akua A.
McFleder, Rhonda L.
Ribechini, Eliana
Blum, Robert
Bruttel, Valentin
Knorr, Susanne
Gehmeyr, Mona
Volkmann, Jens
Brotchie, Jonathan M.
Ahsan, Fadhil
Haack, Beatrice
Monoranu, Camelia-Maria
Keber, Ursula
Yeghiazaryan, Rima
Pagenstecher, Axel
Heckel, Tobias
Bischler, Thorsten
Wischhusen, Joerg
Koprich, James B.
Lutz, Manfred B.
Ip, Chi Wang
BRAIN BEHAVIOR AND IMMUNITY, 2022, 101 : 194 - 210
[27] Restoration of Noradrenergic Function in Parkinson's Disease Model Mice
Cui, Kui
Yang, Fan
Tufan, Turan
Raza, Muhammad U.
Zhan, Yanqiang
Fan, Yan
Zeng, Fei
Brown, Russell W.
Price, Jennifer B.
Jones, Thomas C.
Miller, Gary W.
Zhu, Meng-Yang
ASN NEURO, 2021, 13
[28] Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease
Lin, Chen-Pei
Frigerio, Irene
Bol, John G. J. M.
Bouwman, Maud M. A.
Wesseling, Alex J.
Dahl, Martin J.
Rozemuller, Annemieke J. M.
van der Werf, Ysbrand D.
Pouwels, Petra J. W.
van de Berg, Wilma D. J.
Jonkman, Laura E.
TRANSLATIONAL NEURODEGENERATION, 2024, 13 (01)
[29] Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: Possible role of the noradrenergic nervous system
Szot, Patricia
EPILEPSIA, 2012, 53 : 61 - 66
[30] Neuronal Vulnerability, Pathogenesis, and Parkinson's Disease
Sulzer, David
Surmeier, D. James
MOVEMENT DISORDERS, 2013, 28 (01) : 41 - 50

← 1 2 3 4 5 →